NovaScan
3 known investors
NovaScan develops MarginScan, a compact device combining spectral bioimpedance and AI/ML to detect and localize cancer at the margins of surgical excisions in seconds, for use by surgeons in cancer procedures. The medical device technology, based on the Cole relaxation frequency, targets real-time surgical margin assessment for cancers including skin and breast, and is not yet FDA cleared.
AI & Machine LearningHealthtechMedical Devices
Investors · 3
In the news
Frequently asked questions
- What does NovaScan do?
- NovaScan develops MarginScan, a compact device combining spectral bioimpedance and AI/ML to detect and localize cancer at the margins of surgical excisions in seconds, for use by surgeons in cancer procedures. The medical device technology, based on the Cole relaxation frequency, targets real-time surgical margin assessment for cancers including skin and breast, and is not yet FDA cleared.
- Who are NovaScan's investors?
- NovaScan's investors include Dipalo Ventures, Green Park & Golf Ventures, Portal Innovations.